These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1219 related articles for article (PubMed ID: 25599276)

  • 41. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
    Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.
    Kaloshi G; Roci E; Rroji A; Ducray F; Petrela M
    J Neurosurg; 2015 Nov; 123(5):1244-6. PubMed ID: 26115464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervicomedullary tumors in children.
    McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
    J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
    Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ
    Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.
    Gallo P; Cecchi PC; Locatelli F; Rizzo P; Ghimenton C; Gerosa M; Pinna G
    Br J Neurosurg; 2013 Dec; 27(6):759-64. PubMed ID: 23514331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
    Yordanova YN; Moritz-Gasser S; Duffau H
    J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Aghi MK; Nahed BV; Sloan AE; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):503-30. PubMed ID: 26530265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis.
    Jungk C; Scherer M; Mock A; Capper D; Radbruch A; von Deimling A; Bendszus M; Herold-Mende C; Unterberg A
    J Neurooncol; 2016 Sep; 129(2):319-28. PubMed ID: 27344556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas.
    Yahanda AT; Patel B; Sutherland G; Honeycutt J; Jensen RL; Smyth MD; Limbrick DD; Dacey RG; Dowling JL; Dunn GP; Kim AH; Leuthardt EC; Rich KM; Zipfel GJ; Leonard JR; Cahill DP; Shah MV; Abram SR; Evans J; Tao Y; Chicoine MR
    World Neurosurg; 2020 Mar; 135():e754-e764. PubMed ID: 31901497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
    Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
    Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.
    Patel T; Bander ED; Venn RA; Powell T; Cederquist GY; Schaefer PM; Puchi LA; Akhmerov A; Ogilvie S; Reiner AS; Moussazadeh N; Tabar V
    Neurosurgery; 2018 Jun; 82(6):808-814. PubMed ID: 28945860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.
    Medical Research Council Brain Tumor Working Party
    J Clin Oncol; 2001 Jan; 19(2):509-18. PubMed ID: 11208845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of extent of resection on malignant transformation of pure oligodendrogliomas.
    Snyder LA; Wolf AB; Oppenlander ME; Bina R; Wilson JR; Ashby L; Brachman D; Coons SW; Spetzler RF; Sanai N
    J Neurosurg; 2014 Feb; 120(2):309-14. PubMed ID: 24313617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new philosophy in surgery for diffuse low-grade glioma (DLGG): oncological and functional outcomes.
    Duffau H
    Neurochirurgie; 2013 Feb; 59(1):2-8. PubMed ID: 23410764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcortical insular glioma resection: clinical outcome and predictors.
    Hameed NUF; Qiu T; Zhuang D; Lu J; Yu Z; Wu S; Wu B; Zhu F; Song Y; Chen H; Wu J
    J Neurosurg; 2019 Sep; 131(3):706-716. PubMed ID: 30485243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
    Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
    J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
    Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
    Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors.
    Walker C; Haylock B; Husband D; Joyce KA; Fildes D; Jenkinson MD; Smith T; Broome J; du Plessis DG; Warnke PC
    Neurology; 2006 Jun; 66(11):1661-7. PubMed ID: 16769937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.